MarketPulse — Real-Time Financial News & Market Analysis

Sanofi and Regeneron's Dupixent secured Japanese regulatory approval for bullous pemphigoid, marking the drug's seventh indication in Japan with superior remission rates versus placebo.

Estée Lauder shares fell 7.72% to $79.29 after announcing preliminary merger discussions with Spanish luxury giant Puig Brands. No final decision made; deal pending regulatory approval.

Hormel and General Mills trade at depressed valuations with 5.2% and 6.5% dividend yields amid consumer spending concerns and GLP-1 drug headwinds.

Phonak's AI hearing aids win 2026 excellence awards, featuring advanced environmental recognition and neural networks for improved speech clarity in noisy settings.

Beyond Meat faces securities class action over alleged asset impairment misstatements; lead plaintiff deadline is March 24, 2026.

Rosen Law Firm notifies Corcept investors about securities lawsuit alleging misrepresentation of relacorilant clinical data and concealment of FDA concerns during October 2024-December 2025.

Rosen Law Firm filed securities class action against Concorde International Group ($CIGL) alleging fraudulent promotion schemes and insider share dumping. Affected investors must act before critical deadlines.

BlackRock TCP Capital faces securities lawsuit alleging NAV overstatement and misvaluation. Investors have until April 6, 2026, to join the class action.

Yimutian Inc. acquires enterprise e-commerce platform Ningbo Xunxi Technology for RMB 50 million, expanding beyond agricultural supply chains into digital procurement.

Yimutian acquires Ningbo Xunxi Technology for RMB 50M to combine agricultural supply platform with enterprise procurement capabilities, targeting China's growing digital commerce sector.

Explosion at Valero's Port Arthur refinery causes minor stock decline; 380,000 bpd capacity facility's production impact remains unclear.

Palantir surged 23% in one month on 70% revenue growth and 137% U.S. commercial expansion, but extreme P/E ratio of 255 raises valuation concerns despite solid fundamentals.

Apollo-managed funds agree to acquire Nippon Sheet Glass for $3.7B enterprise value, marking Apollo's largest Japan PE investment. Closing expected by March 2027.

Berkshire Hathaway's $370 billion cash fortress, energy holdings, and diversified insurance operations position it as a defensive safe haven amid geopolitical tensions and elevated oil prices.

Progressive raises $1.5B through senior notes offering at 4.60% and 5.15% coupons, with Goldman Sachs and TD Securities as joint bookrunners.

LOBO Technologies prices $2M public offering of 3.9M units at $0.51 each, with proceeds for EV development and working capital.

Sol-Gel Technologies prices 459,112 shares at $72 each, raising $33.1M for SGT-610 development in Gorlin syndrome treatment.

NHTSA intensifies Full Self-Driving investigation across 3.2M Tesla vehicles over visibility concerns. Potential recall threatens robotaxi ambitions underpinning $1.2T valuation.

Chewy reports Q4 earnings March 25 after 70% five-year decline. Growing subscriptions and marketplace ads suggest undervaluation at 9x EBITDA.

Peloton faces two insurmountable challenges: zero competitive moat against cheaper rivals and cyclical fitness industry with low stickiness. Membership fell 17% to 5.8M; revenue collapsed to $2.5B.